1-5 of 5
Paul J. Petruska
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Acute Myeloid Leukemia Induction with Cladribine: Effects of Age and Leukemia Risk

Free
Martin W. Schoen, MD MPH, Susan K. Woelich, PharmD, BCOP, James T. Braun, Pharm.D, Mark J. Fesler, MD, Paul J. Petruska, MD, Carl E. Freter, MD PhD, Jack M. Lionberger, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3988.
https://doi.org/10.1182/blood.V128.22.3988.3988
Published: 2016
Journal Articles

A Pilot Phase II Study of C-MOPP-R, Ibritumomab Tiuxetan, and Autologous Transplant for Untreated and Relapsed Follicular Lymphoma: Response, Toxicity, and Feasibility,

Free
Mark J. Fesler, MD, Yashaswini Yeragunta, MD, Sheetal A. Majethia, MD, Paul J. Petruska, MD
Journal: Blood
Blood (2011) 118 (21): 4157.
https://doi.org/10.1182/blood.V118.21.4157.4157
Published: 2011
Journal Articles

Cladribine Plus Idarubicin/Cytarabine Induction for Untreated Acute Myeloid Leukemia

Free
Mark J. Fesler, MD, Camille Adeimy, MD, Paul J. Petruska, MD
Journal: Blood
Blood (2011) 118 (21): 4275.
https://doi.org/10.1182/blood.V118.21.4275.4275
Published: 2011
Journal Articles

C-MOPP: Results of a Forgotten Regimen for Follicular Lymphoma in the Era of Rituximab and PET.

Free
Mark J. Fesler, MD, Medhat Osman, MD, ScM, PhD, James Glauber, MD, Paul J. Petruska, MD
Journal: Blood
Blood (2009) 114 (22): 4755.
https://doi.org/10.1182/blood.V114.22.4755.4755
Published: 2009
Journal Articles

Cyclosporine modulation in poor-risk acute myeloid leukemia

Free
Jim V. Beattie, Paul J. Petruska
Journal: Blood
Blood (2002) 100 (1): 366–367.
https://doi.org/10.1182/blood-2002-01-0021
Published: 2002